Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion for 10 Days

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00024674
Recruitment Status : Withdrawn (Support withdrawn - Study continued by NCI - see record NCT00006981)
First Posted : September 25, 2001
Last Update Posted : November 14, 2014
Sponsor:
Information provided by:
INSYS Therapeutics Inc

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Primary Completion Date : No date given
Study Completion Date : No date given